Ariel Dora Stern
机构: Alexander von Humboldt Professor, Hasso Plattner Institute, University of Potsdam
主页: hpi.de
每年引用次数
引用次数
引用: 2,859
H-指数: 26
I10-指数 : 46
出版物: 110
Characterizing the Drug Development Pipeline for Precision Medicines
Amitabh Chandra , Craig Garthwaite , Ariel Dora Stern
National Bureau of Economic Research 115 -157
3
2017
Managing the Use and Dissemination of Information about Biomarkers: The Importance of Incentive Structures.
Ariel Dora Stern
Journal of Law Medicine & Ethics 47 ( 3) 396 -397
2019
Association of the Meaningful Use Electronic Health Record Incentive Program With Health Information Technology Venture Capital Funding.
Samuel Lite , William Joseph Gordon , Ariel Dora Stern ,
JAMA Network Open 3 ( 3)
3
2020
Do state breastfeeding laws in the USA promote breast feeding?
Summer Sherburne Hawkins , Ariel Dora Stern , Matthew W Gillman
Journal of Epidemiology and Community Health 67 ( 3) 250 -256
26
2013
Compliance with the Baby-Friendly Hospital Initiative and impact on breastfeeding rates
Summer Sherburne Hawkins , Ariel Dora Stern , Christopher F Baum , Matthew W Gillman
Archives of Disease in Childhood-fetal and Neonatal Edition 99 ( 2)
76
2014
Review Times and Adverse Events for Cardiovascular Devices
Ariel Dora Stern , Daniel B. Kramer , Melissa Ouellet , Aaron S. Kesselheim
Nature Biomedical Engineering 1 ( 1) 0013
4
2017
Assessing the Food and Drug Administration's Risk-Based Framework for Software Precertification With Top Health Apps in the United States: Quality Improvement Study.
Noy Alon , Ariel Dora Stern , John Torous
Jmir mhealth and uhealth 8 ( 10)
2020
The Impact of the Entry of Biosimilars: Evidence from Europe
Fiona M. Scott Morton , Ariel Dora Stern , Scott Stern
Review of Industrial Organization 53 ( 1) 173 -210
63
2018
Technology Acquisitions: Classic Strategic Management Questions in a New Light
Joachim Henkel , Ariel Dora Stern , Ashish Arora , Christoph Grimpe
Academy of Management Proceedings 2019 ( 1) 19161
2019
Cybersecurity features of digital medical devices: an analysis of FDA product summaries.
Ariel Dora Stern , William J Gordon , Adam B Landman , Daniel B Kramer
BMJ Open 9 ( 6)
5
2019
Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending
David Cutler , Jonathan S. Skinner , Ariel Dora Stern , David Wennberg
American Economic Journal: Economic Policy 11 ( 1) 192 -221
355
2019
Evaluating the impact of the Baby-Friendly Hospital Initiative on breast-feeding rates: a multi-state analysis
Summer Sherburne Hawkins , Ariel Dora Stern , Christopher F Baum , Matthew W Gillman
Public Health Nutrition 18 ( 2) 189 -197
107
2015
The Past, Present, and (Near) Future of Gene Therapy and Gene Editing
Julia Pian , Amitabh Chandra , Ariel Dora Stern
NEJM Catalyst Innovations in Care Delivery 1 ( 5)
1
2020
Innovation Under Regulatory Uncertainty: Evidence from Medical Technology
Ariel Dora Stern
Social Science Research Network
101
2016
AI insurance: how liability insurance can drive the responsible adoption of artificial intelligence in health care
Ariel Dora Stern , Avi Goldfarb , Timo Minssen , W Nicholson Price II
NEJM Catalyst Innovations in Care Delivery 3 ( 4) CAT -21
3
2022
Biosimilars And Follow-On Products In The United States: Adoption, Prices, And Users: Study examines the early years of entry of biosimilar and related follow-on products including sales data, market share, and price trajectory.
Ariel Dora Stern , Jacqueline L Chen , Melissa Ouellet , Mark R Trusheim
Health Affairs 40 ( 6) 989 -999
10
2021
Regulatory, legal, and market aspects of smart wearables for cardiac monitoring
Jan Benedikt Brönneke , Jennifer Müller , Konstantinos Mouratis , Julia Hagen
Sensors 21 ( 14) 4937
17
2021
We should treat algorithms like prescription drugs
Andy Coravos , Irene Chen , Ankit Gordhandas , Ariel Dora Stern
Quartz
13
2019
Germany’s Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries (preprint)
Sara Gerke , Ariel Dora Stern , Timo Minssen
2020
Regulatory Incentives for Pharmaceutical Innovation: The FDA's Breakthrough Therapy Designation
Ashley Swanson , Amitabh Chandra , Jennifer Kao , Ariel Dora Stern
7th Annual Conference of the American Society of Health Economists
2018